Table 2 Active compounds and trade names of the included medications (both original and generics)
Active compounds (plus trade names®) | Participants believing that the active compound is paracetamol (%) |
|---|---|
All participants % (N) | |
Paracetamol | |
 Original (Panadol®) | 87.2 (328) |
 Generic 1 (Depon®) | 50.8 (191) |
 Generic 2 (Apotel®) | 14.1 (53) |
 Paracetamol + Codeine + Caffeine (Solpadeine®) | 49.7 (187) |
NSAIDs | |
 Mefenamic acid (original—Ponstan®) | 29.8 (112) |
 Acetyl-salicylic acid (original—Aspirin®) | 25.8 (97) |
 Nimesulide (generic—Nimm®) | 5.6 (21) |
 Diclofenac (original—Voltaren®) | 13.0 (49) |
Antispasmodics | |
 Hyoscine-N-butylbromide + Paracetamol (original—Buscopan plus®) | 28.5 (107) |